SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 📊Experiments 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Therapy: Autonomic Dysfunction Targeting Therapy for MSA

therapy 1,353 words KG: Biomarker 2026-03-23

kind:therapy-idea section:ideas state:published

Contents

Autonomic Dysfunction Targeting Therapy for MSA

Knowledge Graph

Related Hypotheses (25)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36 Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59

PARP1 Inhibition Therapy
Score: 0.58 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Phase-Separated Organelle Targeting
Score: 0.52 Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51 Ganglioside Rebalancing Therapy
Score: 0.50 Lysosomal Calcium Channel Modulation Therapy
Score: 0.49 Orexin-Microglia Modulation Therapy
Score: 0.49 Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48 Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48 Complement C1q Mimetic Decoy Therapy
Score: 0.48 TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.47 Arginine Methylation Enhancement Therapy
Score: 0.46 Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45 Hypocretin-Neurogenesis Coupling Therapy
Score: 0.45 HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.44 R-Loop Resolution Enhancement Therapy
Score: 0.43 Glial Glycocalyx Remodeling Therapy
Score: 0.41 SIRT6-NAD+ Axis Enhancement Therapy
Score: 0.39 DNMT1-Targeting Antisense Oligonucleotide Reset
Score: 0.36

Related Analyses (23)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived

Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · completed Senolytic therapy for age-related neurodegeneration
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived

Related Experiments (3)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Iron Dyshomeostasis in MSA Pathogenesis Experiment
validation · proposed · Score: 0.40 Cytochrome Therapeutics
clinical · proposed · Score: 0.40

Knowledge Graph (11 edges)

Biomarker biomarker_for Thyroid Cancer

Biomarker correlates_with Disease Trajectory

Biomarker biomarker_for Septic Shock

Biomarker involved_in Sepsis Diagnosis

Biomarker biomarker_for Prostate Cancer

Biomarker biomarker_for Aging

Biomarker biomarker_for Amyotrophic Lateral Sclerosis

Biomarker biomarker_for Frontotemporal Dementia

Biomarker biomarker_for Alzheimer's Disease

HMGB1 biomarker_for Biomarker

SciDEX — scidex.ai — Dashboard | Atlas